A SPECIFIC, SENSITIVE RADIOIMMUNOASSAY FOR PLATELET-ACTIVATING FACTOR (PAF)

被引：28
|
作者：
SMAL, MA
BALDO, BA
MCCASKILL, A
机构：
[1] ROYAL N SHORE HOSP,KOLLING INST MED RES,ST LEONARDS,NSW 2065,AUSTRALIA
[2] SILENUS LABS PTY LTD,HAWTHORN,VIC 3122,AUSTRALIA
[3] UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA
来源：
JOURNAL OF IMMUNOLOGICAL METHODS | 1990年 / 128卷 / 02期
关键词：
Anti-platelet-activating factor; Platelet-activating factor; Platelet-activating factor radioimmunoassay; Quantitation of platelet-activating factor;
D O I：
10.1016/0022-1759(90)90209-E
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
A specific radioimmunoassay (RIA) has been developed for platelet-activating factor (PAF) and shown to be sensitive over the range 10-1000 pg (0.02-2 pmol). The anti-PAF antibodies showed specificity for the acetyl group at the C2 position of the PAF molecule and exhibited no significant cross-reactivity with lyso-PAF or the naturally occurring lipids including lecithin and lysolecithin. The sensitivity of the RIA was at least as good as the platelet-based assays for PAF but the RIA was simpler to perform, had a higher capacity and did not have the drawback of the inherent variability associated with the bioassays. © 1990.
引用
收藏
页码：183 / 188
页数：6
相关论文
共 50 条
  • [31] Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung
    Uhlig, S
    Göggel, R
    Engel, S
    PHARMACOLOGICAL REPORTS, 2005, 57 : 206 - 221
  • [32] PLATELET-ACTIVATING FACTOR (PAF) AS A MEDIATOR OF NEUTROPHIL-PLATELET INTERACTIONS IN INFLAMMATION
    HENSON, PM
    AGENTS AND ACTIONS, 1981, 11 (6-7): : 545 - 547
  • [33] Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
    Ishii, S
    Shimizu, T
    PROGRESS IN LIPID RESEARCH, 2000, 39 (01) : 41 - 82
  • [34] SPECIFIC BINDING OF PLATELET-ACTIVATING FACTOR (PAF) BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR LEUKOCYTES
    NG, DS
    WONG, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (01) : 311 - 316
  • [35] ROLE OF PLATELET-ACTIVATING FACTOR (PAF) IN THE OVOIMPLANTATION IN THE RAT - EFFECT OF THE SPECIFIC PAF-ACETHER ANTAGONIST, BN 52021
    ACKER, G
    HECQUET, F
    ETIENNE, A
    BRAQUET, P
    MENCIAHUERTA, JM
    PROSTAGLANDINS, 1988, 35 (02): : 233 - 241
  • [36] Platelet-activating factor and cardiac diseases: Therapeutic potential for PAF inhibitors
    Feuerstein, G
    Rabinovici, R
    Leor, J
    Winkler, JD
    Vonhof, S
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1997, 15 (03): : 255 - 284
  • [37] The Induction of an Angiogenic Response in Corneal Myofibroblasts by Platelet-Activating Factor (PAF)
    He, Jiucheng
    Eastlack, Jason P.
    Bazan, Haydee E. P.
    CURRENT EYE RESEARCH, 2010, 35 (12) : 1063 - 1071
  • [38] PRESSURE EFFECTS AND EXTRACTION OF PLATELET-ACTIVATING FACTOR (PAF) IN THE ISOLATED LUNG
    FRIEDRICH, T
    LICHEY, J
    FRANKE, J
    OEFF, K
    NIGAM, S
    PRIESNITZ, M
    SINHAR, P
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1982, 18 (06): : P140 - P140
  • [39] The actions,detection and synthesis of platelet-activating factor (PAF) in mammalian pregnancy
    刘玉堂
    隋淑芹
    孙中武
    毕冰
    许翠清
    JournalofForestryResearch, 1998, (04) : 283 - 287
  • [40] PLATELET-ACTIVATING FACTOR (PAF-ACETHER), AN ACTIVATOR OF NEUTROPHIL FUNCTIONS
    JOUVINMARCHE, E
    POITEVIN, B
    BENVENISTE, J
    AGENTS AND ACTIONS, 1982, 12 (5-6): : 716 - 720
12345